Safeguard Scientifics, Inc 

(Public, NYSE:SFE)   Watch this stock   
Find more results for SFE
Nov 4, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 4, 2009
Q3 2009 Earnings Release
Nov 3, 2009
American Electronics Association Classic Financial Conference - Webcast
Oct 7, 2009
America's Growth Capital East Coast Emerging Growth Conference
Oct 7, 2009
Investor Day - Webcast
Oct 6, 2009
William Blair & Company Emerging Growth Stock Conference
Sep 29, 2009
Maxim Group Conference
Sep 15, 2009
Think Equity Growth Conference
Sep 9, 2009
Rodman & Renshaw Annual Global Investment Conference
Aug 28, 2009
Annual Shareholders Meeting
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin - -15.38%
Operating margin - -30.20%
EBITD margin - -25.38%
Return on average assets -13.23% -3.64%
Return on average equity -18.38% -33.18%
Employees 929 -

Address

Building 800 435 Devon Park Drive
Wayne, PA 19087
United States - Map
+1-610-2930600 (Phone)
+1-610-2930601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Safeguard Scientifics, Inc discussed on blogs

Safeguard Scientifics, Inc discussions

  View all discussions »

Description

Safeguard Scientifics, Inc. (Safeguard) is engaged in providing capital, as well as a range of strategic, operational and management resources to its partner companies. Safeguard participates in expansion financings, corporate spin-outs, management buy-outs, recapitalizations, industry consolidations and early-stage financings. The Company concentrates on companies operating in technology and life sciences. The technology-based companies includes companies focused on providing software as a service (SaaS), technology-enabled services and vertical software solutions for healthcare information technology, the financial services sector and Internet-based businesses. On May 6, 2008, the Company completed the sale of its interests in Acsis, Inc., Alliance Consulting Group Associates, Inc., Laureate Pharma, Inc., Neuronyx, Inc. and ProModel Corporation.

Officers and directors

Robert E. Keith Jr.
Chairman of the Board
Age: 67
Bio & Compensation - Reuters
Peter J. Boni
President, Chief Executive Officer, Director
Age: 63
Bio & Compensation - Reuters
Stephen T. Zarrilli
Chief Financial Officer, Senior Vice President
Age: 49
Bio & Compensation - Reuters
James A. Datin
Executive Vice President, Managing Director- Life Sciences
Age: 46
Bio & Compensation - Reuters
Kevin L. Kemmerer
Executive Vice President, Managing Director - Technology Group
Portrait. Age: 40
Bio & Compensation - Reuters
Brian J. Sisko
Senior Vice President, General Counsel
Age: 48
Bio & Compensation - Reuters
Jack L. Messman
Director
Age: 69
Bio & Compensation - Reuters
John W. Poduska Sr.
Director
Age: 71
Bio & Compensation - Reuters
Julie A. Dobson
Director
Age: 52
Bio & Compensation - Reuters
George MacKenzie
Director
Age: 60
Bio & Compensation - Reuters